Donor stem cells that underwent a precise type of genome editing could pave the way for safer, chemotherapy-free transplants, new results in mice show...
Professor Karen Sermon and Sarah Norcross explain why ESHRE and PET have collaborated to publish the wide-ranging report 'Fertility, Embryo Research and Genome Editing: Public Attitudes in Europe'...
The PET team discusses findings from a PET/ESHRE report exploring attitudes to fertility treatment, embryo research, genome editing, donor conception, surrogacy and related topics in the UK, the Netherlands, Spain and Italy...
Using base editing, a highly precise method of genome editing, scientists have investigated the role of the NANOG gene in human embryos for the first time with this approach...
An anti-ageing gene therapy not approved by the US Food and Drug Administration is set to be offered by an American company at overseas clinics outside of US jurisdiction...
The US Food and Drug Administration has proposed allowing manufacturers of cell and gene therapies to make use of existing scientific and platform knowledge during product development...
A CRISPR genome editing therapy provides sustained reductions in 'bad' cholesterol in people with inherited high cholesterol or premature coronary artery disease, an early-stage clinical trial shows...
A transplant of genome-edited stem cells designed to protect healthy donor cells from cancer therapy has shown promise in patients with aggressive blood cancers...
A single-dose CRISPR-based genome-editing therapy for hereditary angioedema has shown positive Phase 3 clinical trial results and entered a step-by-step approval process with US regulators...
A new CRISPR-based approach has been designed to selectively eliminate human cells with disease-causing genes in vitro...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
